Hydroxychloroquine Is Embroiled In Yet More Controversy

Adults (aged ≥18 years) who were hospitalized for less than 48 time with laboratory-confirmed SARS-CoV-2 infections and symptoms of respiratory disease for less than 10 days were enrolled. The primary exclusion standards were more than 1 medication dosage of hydroxychloroquine or chloroquine in the prior 10 times; QTc interval higher than 500 ms; prior receipt… Continue reading Hydroxychloroquine Is Embroiled In Yet More Controversy